Compared with controls, surgery was associated with a lower rate of overall cancer mortality in the highest insulin third (HRadj = 0.64; 95% CI [0.43, 0.97]; p = 0.035), but not in the lower two (Fig 4A), and there was no evidence of a treatment-insulin interaction (p = 0.278). Here, INS is linked to cancer.